Global Zanamivir Market Research Report 2016 Demand, Analysis to 2020

Zanamivir MarketMarket Research Report on Zanamivir begins with definition, application, classification, industry chain analysis, news analysis, region, revenue, forecast, Growth, Trends and policy analysis of the market.

Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.

Browse Zanamivir Full Report With TOC @ http://www.fiormarkets.com/report/global-zanamivir-market-outlook-2016-2021-15370.html

This report provides detailed analysis of worldwide markets for Zanamivir from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Zanamivir market and further lays out an analysis of the factors influencing the supply/demand for Zanamivir, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC’s report, Global Zanamivir Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Zanamivir market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Zanamivir market are GlaxoSmithKline (UK), Simcere (China), Lunan Pharmaceutical (China), among others.

Request For Report Sample @ http://www.fiormarkets.com/report-detail/15370/request-sample

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Zanamivir industry has been provided.

Contact Us

Mark Stone
Sales Manager
2566, Lincoln Street
Princeton,
New Jersey 08540
USA
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

banner